Talaris Therapeutics

OverviewSuggest Edit

Talaris Therapeutics is a late-clinical stage biotechnology company that is developing cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders. The Company's proprietary technology allows candidates for bone marrow transplants to receive hematopoietic stem cells (HSCs) safely from unmatched and unrelated donors, without the toxicity and risks of a traditional bone marrow transplant.

TypePrivate
Founded2002
HQLouisville, US
Websitetalaristx.com

Latest Updates

Employees (est.) (Jan 2020)31(+11%)

Talaris Therapeutics Office Locations

Talaris Therapeutics has an office in Louisville
Louisville, US (HQ)
201 E Jefferson St #110BLouisville
Show all (1)

Talaris Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2002

Talaris Therapeutics total Funding

$100 m

Talaris Therapeutics latest funding size

$100 m

Time since last funding

9 months ago

Talaris Therapeutics investors

Talaris Therapeutics's latest funding round in April 2019 was reported to be $100 m. In total, Talaris Therapeutics has raised $100 m
Show all financial metrics

Talaris Therapeutics Online and Social Media Presence

Embed Graph

Talaris Therapeutics Blogs

20 People to Know in Health Care: Scott Requadt

Louisville Business First features Scott Requadt in their 20 People to Know in Healthcare: FULL STORY The post 20 People to Know in Health Care: Scott Requadt appeared first on Talaris.

Talaris Therapeutics to Present at American Society of Hematology (ASH) Annual Meeting

BOSTON, Mass., and LOUISVILLE, Ky., Dec. 6, 2019 – Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients, announced that founder Dr. Suza…

Talaris Therapeutics Presents Data Supporting Potential of FCR001 to Prevent Recurrence of Kidney-Related Autoimmune Disease in Kidney Transplant Recipients

BOSTON, Mass., and LOUISVILLE, Ky., Nov. 7, 2019 – Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients, today presented data demonstrat…

FDA approves next phase of medical breakthrough in kidney transplants

@WDRBNews reports on Talaris’ Phase 3 trial initiation which will bring our cell therapy to hospitals across the country. Hear from a trial participant about what this treatment means for his life, and for his son who also carries a gene for kidney disease: FULL STORY and video   The post FDA approv…

UofL innovators honored at inaugural EPIC Innovation Awards

This week Talaris founder Dr. Suzanne Ildstad was honored with the Innovator of the Year Award at the @uofl inaugural EPIC Innovation Awards. We are proud of our #Louisville roots and thankful to be a part of this forward-thinking community. Read more:   The post UofL innovators honored at inaugural…

Talaris Therapeutics Announces Initiation of Phase 3 Clinical Trial of FCR001 in Living Donor Kidney Transplant Recipients

Pivotal trial to evaluate the safety and efficacy of novel, investigational cell therapy intended to durably free living donor kidney transplant recipients from immunosuppression BOSTON, Mass., and LOUISVILLE, Ky., Oct. 23, 2019 – Talaris Therapeutics, Inc., a privately held biotechnology company de…
Show more

Talaris Therapeutics Frequently Asked Questions

  • When was Talaris Therapeutics founded?

    Talaris Therapeutics was founded in 2002.

  • How many employees does Talaris Therapeutics have?

    Talaris Therapeutics has 31 employees.

  • Who are Talaris Therapeutics competitors?

    Competitors of Talaris Therapeutics include RootPath Genomics, OncoMyx Therapeutics and Bolt Biotherapeutics.

  • Where is Talaris Therapeutics headquarters?

    Talaris Therapeutics headquarters is located at 201 E Jefferson St #110BLouisville, Louisville.

  • Where are Talaris Therapeutics offices?

    Talaris Therapeutics has an office in Louisville.

  • How many offices does Talaris Therapeutics have?

    Talaris Therapeutics has 1 office.